These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28259148)

  • 21. Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study.
    Sayah FA; Bansback N; Bryan S; Ohinmaa A; Poissant L; Pullenayegum E; Xie F; Johnson JA
    Qual Life Res; 2016 Jul; 25(7):1679-85. PubMed ID: 26659899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Burden of epilepsy in rural Kenya measured in disability-adjusted life years.
    Ibinda F; Wagner RG; Bertram MY; Ngugi AK; Bauni E; Vos T; Sander JW; Newton CR
    Epilepsia; 2014 Oct; 55(10):1626-33. PubMed ID: 25131901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
    Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
    Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time trade-off and ranking exercises are sensitive to different dimensions of EQ-5D health states.
    Rand-Hendriksen K; Augestad LA
    Value Health; 2012; 15(5):777-82. PubMed ID: 22867789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Describing the Development of a Health State Valuation Protocol to Obtain Community-Derived Disability Weights.
    Lobo E; Nanda L; Akhouri SS; Shrivastava C; Ronghang R; Menon GR; Dutta A
    Front Public Health; 2019; 7():276. PubMed ID: 31681720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Similar responses to EQ-5D-3L by two elicitation methods: visual analogue scale and time trade-off.
    Wang X; Zhuo L; Ma Y; Cai T; Must A; Xu L; Zhuo L
    BMC Med Res Methodol; 2020 May; 20(1):118. PubMed ID: 32410582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valuation of health states in the US study to establish disability weights: lessons from the literature.
    Rehm J; Frick U
    Int J Methods Psychiatr Res; 2010 Mar; 19(1):18-33. PubMed ID: 20191661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disability weight measurement for the severity of different diseases in Wuhan, China.
    Liu X; Guo Y; Wang F; Yu Y; Yan Y; Wen H; Shi F; Wang Y; Wang X; Shen H; Li S; Gong Y; Ke S; Zhang W; Jin Q; Zhang G; Wu Y; Zhou M; Yu C
    Popul Health Metr; 2023 May; 21(1):5. PubMed ID: 37143047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canadian valuation of EQ-5D health states: preliminary value set and considerations for future valuation studies.
    Bansback N; Tsuchiya A; Brazier J; Anis A
    PLoS One; 2012; 7(2):e31115. PubMed ID: 22328929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eliciting national and subnational sets of disability weights in mainland China: Findings from the Chinese disability weight measurement study.
    Liu X; Wang F; Yu C; Zhou M; Yu Y; Qi J; Yin P; Yu S; Zhou Y; Lin L; Liu Y; Wang Q; Zhong W; Huang S; Li Y; Liu L; Liu Y; Ma F; Zhang Y; Tian Y; Yu Q; Zeng J; Pan J; Zhou M; Kang W; Zhou JY; Yu H; Liu Y; Li S; Yu H; Wang C; Xia T; Xi J; Ren X; Xing X; Cheng Q; Fei F; Wang D; Zhang S; He Y; Wen H; Liu Y; Shi F; Wang Y; Sun P; Bai J; Wang X; Shen H; Ma Y; Yang D; Mubarik S; Cao J; Meng R; Zhang Y; Guo Y; Yan Y; Zhang W; Ke S; Zhang R; Wang D; Zhang T; Nomura S; Hay SI; Salomon JA; Haagsma JA; Murray CJL; Vos T
    Lancet Reg Health West Pac; 2022 Sep; 26():100520. PubMed ID: 35910433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of health utility scores calculated using United Kingdom and Canadian preference weights in persons with alzheimer's disease and their caregivers.
    Fang M; Oremus M; Tarride JE; Raina P;
    Health Qual Life Outcomes; 2016 Jul; 14(1):105. PubMed ID: 27431327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methodological considerations in injury burden of disease studies across Europe: a systematic literature review.
    Charalampous P; Pallari E; Gorasso V; von der Lippe E; Devleesschauwer B; Pires SM; Plass D; Idavain J; Ngwa CH; Noguer I; Padron-Monedero A; Sarmiento R; Majdan M; Ádám B; AlKerwi A; Cilovic-Lagarija S; Clarsen B; Corso B; Cuschieri S; Dopelt K; Economou M; Fischer F; Freitas A; García-González JM; Gazzelloni F; Gkitakou A; Gulmez H; Hynds P; Isola G; Jakobsen LS; Kabir Z; Kissimova-Skarbek K; Knudsen AK; Konar NM; Ladeira C; Lassen B; Liew A; Majer M; Mechili EA; Mereke A; Monasta L; Mondello S; Morgado JN; Nena E; Ng ESW; Niranjan V; Nola IA; O'Caoimh R; Petrou P; Pinheiro V; Ortiz MR; Riva S; Samouda H; Santos JV; Santoso CMA; Milicevic MS; Skempes D; Sousa AC; Speybroeck N; Tozija F; Unim B; Uysal HB; Vaccaro FG; Varga O; Vasic M; Violante FS; Wyper GMA; Polinder S; Haagsma JA
    BMC Public Health; 2022 Aug; 22(1):1564. PubMed ID: 35978333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valuation of the EQ-5D-5L with composite time trade-off for the German population - an exploratory study.
    Ludwig K; von der Schulenburg JG; Greiner W
    Health Qual Life Outcomes; 2017 Feb; 15(1):39. PubMed ID: 28219389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health utility scores in Alzheimer's disease: differences based on calculation with American and Canadian preference weights.
    Oremus M; Tarride JE; Clayton N; ; Raina P
    Value Health; 2014; 17(1):77-83. PubMed ID: 24438720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How dead is dead? Qualitative findings from participants of combined traditional and lead-time time trade-off valuations.
    Al Sayah F; Mladenovic A; Gaebel K; Xie F; Johnson JA
    Qual Life Res; 2016 Jan; 25(1):35-43. PubMed ID: 26216584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valuation of EQ-5D-3L health states in Singapore: modeling of time trade-off values for 80 empirically observed health states.
    Luo N; Wang P; Thumboo J; Lim YW; Vrijhoef HJ
    Pharmacoeconomics; 2014 May; 32(5):495-507. PubMed ID: 24519603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods.
    Yusof FA; Goh A; Azmi S
    Value Health; 2012; 15(1 Suppl):S85-90. PubMed ID: 22265073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Estimation of disability weights on malignant neoplasms in Shandong province].
    Ma JX; Sun JD; Fu ZT; Xu AQ; Guo XL; Lu ZL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Dec; 29(12):1208-12. PubMed ID: 19173965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time trade-off and attitudes toward euthanasia: implications of using 'death' as an anchor in health state valuation.
    Augestad LA; Rand-Hendriksen K; Stavem K; Kristiansen IS
    Qual Life Res; 2013 May; 22(4):705-14. PubMed ID: 22678351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inconsistencies in TTO and VAS values for EQ-5D health states.
    Lamers LM; Stalmeier PF; Krabbe PF; Busschbach JJ
    Med Decis Making; 2006; 26(2):173-81. PubMed ID: 16525171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.